Sources Sought Contract Vialing of Monoclonal Antibody NB645030-25-01699

National Institute of Standards and Technology (NIST) Acquisition Management Division Sources Sought for Commercial Product Purchase THIS SOURCES SOUGHT IS NOT A REQUEST FOR QUOTATION. It is a market research tool being used to determine potential and eligible business firms that can provide the product described herein prior to determining the method of acquisition. The National Institute of Standards & Technology (NIST) seeks information on vendors that can provide Contract Vialing of Monoclonal Antibody Reference Material per the specifications attached herein. This announcement is not a Request for Proposals or Quotes (RFP/RFQ) and does not commit the Government to award a contract now or in the future. The information contained in this notice is DRAFT only and, as such, is subject to change prior to the issuance of a solicitation. No solicitation is available currently. Additionally, the Government is not obligated to and will not pay for any information received from potential sources because of this Sources Sought announcement. The results of this Sources Sought will be utilized to determine if any Small Business Set-aside opportunities exist. All Small Business Set-aside categories will be considered. In addition, this market research tool is being used to identify potential and eligible firms, of all sizes, who manufacture in the U.S. prior to determining the method of acquisition and issuance of a solicitation. After the results of this market research are obtained and analyzed, NIST may conduct a competitive or non-competitive procurement on the System for Award Management (sam.gov) and subsequently award a contract. If at least two qualified small businesses are identified during this market research stage that can fulfill the requirement, in accordance with the Specifications, then this acquisition shall be solicited as a small business set aside, however, NIST is seeking responses from ALL responsible sources, including large and small businesses. Responses should include the country where the product is manufactured. This requirement is assigned a NAICS code of 541714, Research and Development in Biotechnology (except Nanobiotechnology), with a small business size standard of 1,000 employees. Interested business organizations that believe they can meet the requirements should submit electronic copies of their capability statement. Responses should include the following information: Name of the company that will provide the product(s). Name of the company that will manufacture the product. County of origin or manufacture of the product. Spec/data sheets and examples of products that meet the specifications that demonstrate experience in meeting the requirements of this procurement. Typical lead time to deliver the product after receipt of order Any other relevant information that is not listed above that the Government should consider in developing its minimum specifications and finalizing its market research. (Company sales brochures or marketing packages will not be considered.) Any proprietary information should be so marked. The written capability statement should be received by the Contracting Officer, Angela Hitt, via email at angela.hitt@nist.gov no later than the date and time posted in this notice. No quotes will be accepted at this time and will not be considered. REQUIREMENTS OVERVIEW: See the attached Statement of Work document.

The purpose of Amendment 1 is to change the NAICS code 541714 to 325414. All other terms and conditions remain unchanged. National Institute of Standards and Technology (NIST) Acquisition Management Division Sources Sought for Commercial Product Purchase THIS SOURCES SOUGHT IS NOT A REQUEST FOR QUOTATION. It is a market research tool being used to determine potential and eligible business firms that can provide the product described herein prior to determining the method of acquisition. The National Institute of Standards & Technology (NIST) seeks information on vendors that can provide Contract Vialing of Monoclonal Antibody Reference Material per the specifications attached herein. This announcement is not a Request for Proposals or Quotes (RFP/RFQ) and does not commit the Government to award a contract now or in the future. The information contained in this notice is DRAFT only and, as such, is subject to change prior to the issuance of a solicitation. No solicitation is available currently. Additionally, the Government is not obligated to and will not pay for any information received from potential sources because of this Sources Sought announcement. The results of this Sources Sought will be utilized to determine if any Small Business Set-aside opportunities exist. All Small Business Set-aside categories will be considered. In addition, this market research tool is being used to identify potential and eligible firms, of all sizes, who manufacture in the U.S. prior to determining the method of acquisition and issuance of a solicitation. After the results of this market research are obtained and analyzed, NIST may conduct a competitive or non-competitive procurement on the System for Award Management (sam.gov) and subsequently award a contract. If at least two qualified small businesses are identified during this market research stage that can fulfill the requirement, in accordance with the Specifications, then this acquisition shall be solicited as a small business set aside, however, NIST is seeking responses from ALL responsible sources, including large and small businesses. Responses should include the country where the product is manufactured. This requirement is assigned a NAICS code of 541714, Research and Development in Biotechnology (except Nanobiotechnology), with a small business size standard of 1,000 employees. Interested business organizations that believe they can meet the requirements should submit electronic copies of their capability statement. Responses should include the following information: Name of the company that will provide the product(s). Name of the company that will manufacture the product. County of origin or manufacture of the product. Spec/data sheets and examples of products that meet the specifications that demonstrate experience in meeting the requirements of this procurement. Typical lead time to deliver the product after receipt of order Any other relevant information that is not listed above that the Government should consider in developing its minimum specifications and finalizing its market research. (Company sales brochures or marketing packages will not be considered.) Any proprietary information should be so marked. The written capability statement should be received by the Contracting Officer, Angela Hitt, via email at angela.hitt@nist.gov no later than the date and time posted in this notice. No quotes will be accepted at this time and will not be considered. REQUIREMENTS OVERVIEW: See the attached Statement of Work document.

This solicitation is being issued as a Request for Quotation (RFQ). All communications and documents must include the solicitation number NB645030-25-01699. The contracting officer will not use, nor this solicitation be subject to the formal source selection procedures described in FAR Part 15. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-05. The National Institute of Standards and Technology (NIST), Acquisition Management Division (AMD), Team E-Boulder has a requirement for Gaithersburg for Monoclonal Antibody Reference Material Vialing in accordance with the Statement of Work and RFQ documents.

The purpose of Amendment 1 is upload the Material Safety Data Sheet and the Certificate for the 8671 Material. All other terms and conditions remain unchanged. This solicitation is being issued as a Request for Quotation (RFQ). All communications and documents must include the solicitation number NB645030-25-01699. The contracting officer will not use, nor this solicitation be subject to the formal source selection procedures described in FAR Part 15. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-05. The National Institute of Standards and Technology (NIST), Acquisition Management Division (AMD), Team E-Boulder has a requirement for Gaithersburg for Monoclonal Antibody Reference Material Vialing in accordance with the Statement of Work and RFQ documents.

The purpose of Amendment 3 is to upload another revised Statement of Work. All other terms and conditions remain unchanged. The purpose of Amendment 2 is to upload questions and answers and to update the Statement of Work. All other terms and conditions remain unchanged. The purpose of Amendment 1 is upload the Material Safety Data Sheet and the Certificate for the 8671 Material. All other terms and conditions remain unchanged. This solicitation is being issued as a Request for Quotation (RFQ). All communications and documents must include the solicitation number NB645030-25-01699. The contracting officer will not use, nor this solicitation be subject to the formal source selection procedures described in FAR Part 15. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-05. The National Institute of Standards and Technology (NIST), Acquisition Management Division (AMD), Team E-Boulder has a requirement for Gaithersburg for Monoclonal Antibody Reference Material Vialing in accordance with the Statement of Work and RFQ documents.